IntraGly-FB Inhaler by Intra Life is a prescription triple-combination respiratory formulation containing Glycopyrrolate, Formoterol Fumarate and Budesonide. It combines a long-acting muscarinic antagonist (LAMA), long-acting beta-2 agonist (LABA) and inhaled corticosteroid (ICS).
This class of inhaled triple therapy is used for maintenance treatment in selected adults with chronic obstructive pulmonary disease (COPD), where the specific product is authorized and prescribed. Glycopyrrolate blocks muscarinic-mediated bronchoconstriction; Formoterol supports long-acting bronchodilation by stimulating beta-2 receptors; and Budesonide acts as an inhaled anti-inflammatory corticosteroid.
IntraGly-FB is not a rescue inhaler for sudden breathing attacks. Confirm approved indications, active ingredient strengths, dosing regimen and precautions from the official label before publishing.
| Clinical area | Explanation |
|---|---|
| COPD maintenance treatment | Triple inhaled therapy may be prescribed for selected adults needing ongoing maintenance treatment. |
| Persistent airflow limitation | Long-acting bronchodilators help keep airways more open over time. |
| COPD exacerbation management | In selected patients, adding an ICS may reduce exacerbation frequency; individual risks and benefits vary. |
| Chronic bronchitis / emphysema with COPD | May be part of the maintenance plan when approved and clinically appropriate. |
Triple inhaled therapy is not suitable for all COPD patients. Budesonide-containing COPD therapy may increase pneumonia risk. Do not claim approval for asthma or other conditions without product-specific evidence.
| Parameter | Details |
|---|---|
| Brand | IntraGly-FB |
| Company | Intra Life |
| Active ingredients | Glycopyrrolate; Formoterol Fumarate; Budesonide |
| Exact strengths | Verify approved label (not clearly visible) |
| Form | Inhaler; exact device mechanism to confirm |
| Pack size | 120 Metered Doses |
| Drug class | LAMA + LABA + ICS |
| Segment | Respiratory / Pulmonology |
| Route | Oral inhalation |
| Prescription status | Rx |
| Storage | As stated in approved product instructions |
A fixed dose or number of puffs for IntraGly-FB cannot be determined safely from the photograph. Use the approved prescribing leaflet and prescriber instructions. The following describes general inhaler principles and does not replace device-specific training.
What is IntraGly-FB Inhaler used for?
Triple therapy of this class is used for COPD maintenance in selected patients, subject to product-specific authorization.
What is its composition?
Glycopyrrolate, Formoterol Fumarate and Budesonide; exact strengths require label verification.
Is it a triple therapy inhaler?
Yes. It combines LAMA, LABA and ICS components.
How many doses are included?
The packaging states 120 metered doses.
Can it treat a sudden asthma attack?
No. This is not an emergency rescue inhaler.
What are potential adverse effects?
Oral thrush, hoarseness, dry mouth, tremor, palpitations and others; serious risks need professional review.
Should I rinse my mouth after inhalation?
Yes. Rinsing and spitting helps reduce steroid-associated oral thrush.
What therapeutic segment does it belong to?
Respiratory / Pulmonology.
Is it available without a prescription?
The pack states Rx; supply must comply with prescription requirements.
How can distributors enquire?
Contact Intra Life through verified official trade channels.